PSTV

Plus Therapeutics, Inc. is a pioneering clinical-stage pharmaceutical company headquartered in Austin, Texas, dedicated to advancing innovative cancer therapies and treatments for serious diseases. The company leverages proprietary drug delivery technologies to enhance therapeutic efficacy in oncology, positioning it to tackle significant unmet medical needs within the healthcare landscape. With a robust pipeline of promising drug candidates, Plus Therapeutics is committed to improving patient outcomes and elevating the standard of care in oncology, making it an attractive consideration for investors focused on the future of cancer treatment.